Virinder S Parmar Selected Research

7,8-dihydroxy-4-methylcoumarin

1/2018	Oxidative Stress Induces HSP90 Upregulation on the Surface of Primary Human Endothelial Cells: Role of the Antioxidant 7,8-Dihydroxy-4-methylcoumarin in Preventing HSP90 Exposure to the Immune System.
9/2010	In vitro interactions of coumarins with iron.
5/2007	7,8-Dihydroxy-4-methylcoumarin induces apoptosis of human lung adenocarcinoma cells by ROS-independent mitochondrial pathway through partial inhibition of ERK/MAPK signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virinder S Parmar Research Topics

Disease

9	Neoplasms (Cancer) 09/2021 - 03/2003
7	Inflammation (Inflammations) 01/2013 - 03/2004
4	Breast Neoplasms (Breast Cancer) 03/2015 - 03/2005
2	Glioma (Gliomas) 09/2021 - 01/2014
2	Botulism 01/2021 - 12/2018
2	Infections 01/2020 - 12/2016
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 09/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2011 - 09/2010
2	Necrosis 09/2010 - 11/2002
2	Adenocarcinoma of Lung 05/2009 - 05/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2009 - 05/2007
1	Invasive Fungal Infections 01/2022
1	Acute Radiation Syndrome 10/2019
1	Paralysis (Palsy) 12/2018
1	Neuroblastoma 12/2018
1	Carotid Artery Diseases 01/2018
1	Atherosclerotic Plaque (Atheroma) 01/2018
1	Adenocarcinoma 01/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016
1	Drug-Related Side Effects and Adverse Reactions 01/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2014
1	Asthma (Bronchial Asthma) 01/2013
1	Fibrosis (Cirrhosis) 01/2013
1	Metaplasia 01/2013
1	Respiratory Hypersensitivity 01/2013
1	Airway Remodeling 01/2013
1	Thrombosis (Thrombus) 09/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2011
1	Myalgia 07/2011
1	Pulmonary Hypertension 07/2011
1	Rhabdomyolysis 07/2011
1	Carcinogenesis 06/2011
1	Myocardial Infarction 09/2010

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 09/2021 - 03/2011
4	Pharmaceutical PreparationsIBA 01/2022 - 09/2007
4	CalreticulinIBA 09/2021 - 03/2011
4	Acetates (Acetic Acid Esters)FDA Link 09/2021 - 01/2014
4	Cell Adhesion MoleculesIBA 09/2010 - 03/2004
3	AntioxidantsIBA 01/2018 - 05/2009
3	7,8-dihydroxy-4-methylcoumarinIBA 01/2018 - 05/2007
3	CoumarinsIBA 01/2016 - 03/2003
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2011 - 03/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2011 - 11/2002
2	incobotulinumtoxinA FDA Link 01/2021 - 12/2018
2	Biological ProductsIBA 12/2018 - 04/2011
2	IronIBA 12/2016 - 09/2010
2	Estrogens (Estrogen)FDA Link 03/2015 - 09/2011
2	LactonesIBA 12/2014 - 03/2003
2	coumarinIBA 01/2014 - 05/2009
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	ElementsIBA 10/2019
1	Botulinum Toxins (Botulinum Toxin)IBA 12/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2018
1	SNARE Proteins (SNAREs)IBA 12/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 12/2018
1	N-Ethylmaleimide-Sensitive Proteins (N-Ethylmaleimide-Sensitive Fusion Protein)IBA 12/2018
1	EndopeptidasesIBA 12/2018
1	Histone Deacetylase InhibitorsIBA 02/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018
1	Staphylococcal Protein A (Protein A)IBA 01/2018
1	SiderophoresIBA 12/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2015
1	EpitopesIBA 06/2015
1	Hematoxylin (Haematoxylon)IBA 06/2015
1	Selective Estrogen Receptor Modulators (SERM)IBA 03/2015
1	Methyl EthersIBA 03/2015
1	AlkaloidsIBA 12/2014
1	AlcoholsIBA 12/2014
1	spiroketalIBA 12/2014
1	PyrrolesIBA 12/2014
1	Histones (Histone)IBA 01/2014
1	CytokinesIBA 01/2013
1	OvalbuminIBA 01/2013
1	AcidsIBA 01/2013
1	8-epi-prostaglandin F2alphaIBA 01/2013
1	CinnamatesIBA 01/2013
1	ferric chlorideIBA 09/2011
1	Oxidoreductases (Dehydrogenase)IBA 07/2011
1	ethyl 4- (4'- heptanoyloxyphenyl)- 6- methyl- 3,4- dihydropyrimidin- 2- one- 5- carboxylateIBA 07/2011
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 07/2011
1	Coenzyme A (CoA)IBA 07/2011
1	oxidized low density lipoproteinIBA 07/2011
1	Protein Isoforms (Isoforms)IBA 07/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2011
1	Protein Kinase CIBA 07/2011
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2011
1	EnzymesIBA 06/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2010
1	src-Family KinasesIBA 09/2010
1	IonsIBA 09/2010
1	Complex MixturesIBA 09/2010
1	Deferoxamine (Desferal)FDA LinkGeneric 09/2010
1	NucleosidesIBA 09/2010
1	Chelating AgentsIBA 09/2010
1	7,8-diacetoxy-4-methylthiocoumarinIBA 05/2009
1	Phosphotransferases (Kinase)IBA 05/2009

Therapy/Procedure

4	Therapeutics 02/2018 - 03/2011
2	Drug Therapy (Chemotherapy) 03/2011 - 09/2010
1	Immunotherapy 02/2018